Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer

Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer

Tertiary lymphoid structures (TLS) existence is correlated with favorable prognosis in many types of cancer including non-small cell lung cancer (NSCLC). However, TLS formation and its relationship with treatment response remains unknown in NSCLC who received anti-PD-1 antibody plus chemotherapy as...

Full description

Bibliographic Details
Main Authors: Chen Chen, Jingjing Li, Bin Zhang, Chenguang Li, Dongsheng Yue, Changli Wang, Xinyi Wu, Weiran Liu, Xiaoyan Sun, Leina Sun, Huilan Mo, Yingnan Feng, Ying Xin, Zhenfa Zhang
Format: Article
Language:English
Published: BMJ Publishing Group 2022-11-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/10/11/e005531.full

Internet

https://jitc.bmj.com/content/10/11/e005531.full

Similar Items